Emerald Health Therapeutics Inc (EMH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 4,272 | 9,298 | 4,619 | 2,130 | 970 |
| Cost of Goods | 11,198 | 13,853 | 5,955 | 3,783 | 5,231 |
| Gross Profit | -6,925 | -4,555 | -1,335 | -1,653 | -4,262 |
| Operating Expenses | 5,695 | 10,140 | 12,443 | 8,265 | 10,844 |
| Operating Income | -12,620 | -14,695 | -13,778 | -9,918 | -15,106 |
| Other Income | -78,018 | -3,570 | 13,326 | 6,269 | 1,500 |
| Pre-tax Income | -90,638 | -18,266 | -453 | -3,649 | -13,606 |
| Income Tax | -294 | -805 | 0 | 0 | 294 |
| Net Income Continuous | -90,344 | -17,461 | -453 | -3,649 | -13,900 |
| Minority Interests | 175 | 208 | 177 | 205 | 0 |
| Net Income | $-90,169 | $-17,253 | $-275 | $-3,444 | $-13,900 |
| EPS Basic Total Ops | -0.60 | -0.12 | 0.00 | -0.03 | -0.09 |
| EPS Basic Continuous Ops | -0.60 | -0.12 | 0.00 | -0.03 | -0.09 |
| EPS Diluted Total Ops | -0.60 | -0.12 | 0.00 | -0.03 | -0.09 |
| EPS Diluted Continuous Ops | -0.60 | -0.12 | 0.00 | -0.03 | -0.09 |
| EBITDA(a) | $-10,443 | $-12,928 | $-12,555 | $-8,656 | $-7,496 |